QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.106.030023v1 71/5/1416    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Navratilova, E. Articles by Varga, E. V. Search for Related Content PubMed PubMed Citation Articles by Navratilova, E. Articles by Varga, E. V.

Quantitative Evaluation of Human Opioid Receptor Desensitization Using the Operational Model of Drug Action

Departments of Medical Pharmacology (E.N., S.W., D.S., M.C.E., V.J.H., W.R.R., H.I.Y., E.V.V.), Biochemistry and Molecular Biophysics (I.D.A., V.J.H., H.I.Y.), Chemistry (V.J.H.), Psychiatry (H.I.Y.), Medicine (V.J.H., W.R.R.), and the Sarver Heart Center (W.R.R., H.I.Y., E.V.V.), The University of Arizona, Tucson, Arizona

Agonist-mediated desensitization of the opioid receptors is thought to function as a protective mechanism against sustained opioid signaling and therefore may prevent the development of opioid tolerance. However, the exact molecular mechanism of opioid receptor desensitization remains unresolved because of difficulties in measuring and interpreting receptor desensitization. In the present study, we investigated deltorphin II-mediated rapid desensitization of the human opioid receptors (hDOR) by measuring guanosine 5'-O-(3-[³⁵S]thio)-triphosphate binding and inhibition of cAMP accumulation. We developed a mathematical analysis based on the operational model of agonist action (Black et al., 1985) to calculate the proportion of desensitized receptors. This approach permits a correct analysis of the complex process of functional desensitization by taking into account receptor-effector coupling and the time dependence of agonist pretreatment. Finally, we compared hDOR desensitization with receptor phosphorylation at Ser363, the translocation of -arrestin2, and hDOR internalization. We found that in Chinese hamster ovary cells expressing the hDOR, deltorphin II treatment leads to phosphorylation of Ser363, translocation of -arrestin2 to the plasma membrane, receptor internalization, and uncoupling from G proteins. It is noteworthy that mutation of the primary phosphorylation site Ser363 to alanine had virtually no effect on agonist-induced -arrestin2 translocation and receptor internalization yet significantly attenuated receptor desensitization. These results strongly indicate that phosphorylation of Ser363 is the primary mechanism of hDOR desensitization.

Address correspondence to: Dr. Eva V. Varga, Department of Medical Pharmacology, College of Medicine, The University of Arizona Health Sciences Center, Tucson, AZ 85724. E-mail: evarga{at}u.arizona.edu